Literature DB >> 17431012

Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study.

Suzanne L Tyas1, Juan Carlos Salazar, David A Snowdon, Mark F Desrosiers, Kathryn P Riley, Marta S Mendiondo, Richard J Kryscio.   

Abstract

The potential of early interventions for dementia has increased interest in cognitive impairments less severe than dementia. However, predictors of the trajectory from intact cognition to dementia have not yet been clearly identified. The purpose of this study was to determine whether known risk factors for dementia increased the risk of mild cognitive impairments or progression from mild cognitive impairments to dementia. A polytomous logistic regression model was used, with parameters governing transitions within transient states (intact cognition, mild cognitive impairments, global impairment) estimated separately from parameters governing the transition from transient to absorbing state (dementia or death). Analyses were based on seven annual examinations (1991-2002) of 470 Nun Study participants aged > or = 75 years at baseline and living in the United States. Odds of developing dementia increased with age primarily for those with low educational levels. In these women, presence of an apolipoprotein E gene *E4 allele increased the odds more than fourfold by age 95 years. Age, education, and the apolipoprotein E gene were all significantly associated with mild cognitive impairments. Only age, however, was associated with progression to dementia. Thus, risk factors for dementia may operate primarily by predisposing individuals to develop mild cognitive impairments; subsequent progression to dementia then depends on only time and competing mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431012      PMCID: PMC2516202          DOI: 10.1093/aje/kwm085

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  39 in total

1.  Mild cognitive impairment: further caution.

Authors:  E Milwain
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment.

Authors:  Katie Palmer; Laura Fratiglioni; Bengt Winblad
Journal:  Acta Neurol Scand Suppl       Date:  2003

Review 3.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

4.  The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.

Authors:  Neelum T Aggarwal; Robert S Wilson; Todd L Beck; Julia L Bienias; Elizabeth Berry-Kravis; David A Bennett
Journal:  Neurocase       Date:  2005-02       Impact factor: 0.881

5.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

Authors:  K A Welsh; N Butters; R C Mohs; D Beekly; S Edland; G Fillenbaum; A Heyman
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

6.  Classification criteria for mild cognitive impairment: a population-based validation study.

Authors:  K Ritchie; S Artero; J Touchon
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

7.  Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.

Authors:  Susanna Tervo; Miia Kivipelto; Tuomo Hänninen; Matti Vanhanen; Merja Hallikainen; Arto Mannermaa; Hilkka Soininen
Journal:  Dement Geriatr Cogn Disord       Date:  2004-01-20       Impact factor: 2.959

8.  Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.

Authors:  Ging-Yuek R Hsiung; A Dessa Sadovnick; Howard Feldman
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

9.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

10.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

Authors:  Kathryn P Riley; David A Snowdon; William R Markesbery
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

View more
  59 in total

1.  Preventing cognitive decline in older African Americans with mild cognitive impairment: design and methods of a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Benjamin E Leiby
Journal:  Contemp Clin Trials       Date:  2012-03-02       Impact factor: 2.226

Review 2.  Selection bias in rheumatic disease research.

Authors:  Hyon K Choi; Uyen-Sa Nguyen; Jingbo Niu; Goodarz Danaei; Yuqing Zhang
Journal:  Nat Rev Rheumatol       Date:  2014-04-01       Impact factor: 20.543

3.  The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging.

Authors:  R O Roberts; Y E Geda; D S Knopman; R H Cha; V S Pankratz; B F Boeve; E G Tangalos; R J Ivnik; W A Rocca; R C Petersen
Journal:  Neurology       Date:  2012-01-25       Impact factor: 9.910

4.  Does cognition predict mortality in midlife? Results from the Whitehall II cohort study.

Authors:  Séverine Sabia; Alice Guéguen; Michael G Marmot; Martin J Shipley; Joël Ankri; Archana Singh-Manoux
Journal:  Neurobiol Aging       Date:  2008-06-09       Impact factor: 4.673

5.  Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease.

Authors:  Steven E Arnold; Natalia Louneva; Kajia Cao; Li-San Wang; Li-Ying Han; David A Wolk; Selamawit Negash; Sue E Leurgans; Julie A Schneider; Aron S Buchman; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2012-05-02       Impact factor: 4.673

Review 6.  Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biochem Pharmacol       Date:  2014-01-04       Impact factor: 5.858

Review 7.  Risk factors for the progression of mild cognitive impairment to dementia.

Authors:  Noll L Campbell; Fred Unverzagt; Michael A LaMantia; Babar A Khan; Malaz A Boustani
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

8.  The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.

Authors:  Patricia A Boyle; Aron S Buchman; Robert S Wilson; Jeremiah F Kelly; David A Bennett
Journal:  Neuroepidemiology       Date:  2009-11-11       Impact factor: 3.282

9.  A nonstationary Markov transition model for computing the relative risk of dementia before death.

Authors:  Lei Yu; William S Griffith; Suzanne L Tyas; David A Snowdon; Richard J Kryscio
Journal:  Stat Med       Date:  2010-03-15       Impact factor: 2.373

10.  Factors associated with cognition in adults: the Seattle Longitudinal Study.

Authors:  Fang Yu; Lindsay H Ryan; K Warner Schaie; Sherry L Willis; Ann Kolanowski
Journal:  Res Nurs Health       Date:  2009-10       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.